Comments
Loading...

PDS Biotechnology

PDSBNASDAQ
Logo brought to you by Benzinga Data
$3.23
0.092.95%
Pre-Market: 9:15 AM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$21.00
Lowest Price Target1
$7.00
Consensus Price Target1
$14.60

PDS Biotechnology (NASDAQ:PDSB) Stock, Analyst Ratings, Price Targets, Forecasts

PDS Biotechnology Corp has a consensus price target of $14.6 based on the ratings of 6 analysts. The high is $21 issued by HC Wainwright & Co. on September 17, 2024. The low is $7 issued by Alliance Global Partners on August 20, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Alliance Global Partners, and HC Wainwright & Co. on September 17, 2024, August 20, 2024, and August 1, 2024, respectively. With an average price target of $16.33 between HC Wainwright & Co., Alliance Global Partners, and HC Wainwright & Co., there's an implied 405.28% upside for PDS Biotechnology Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
1
May
0
0
0
0
Jun
0
0
0
0
Aug
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Alliance Global Partners
B. Riley Securities
Oppenheimer
Chardan Capital

1calculated from analyst ratings

Analyst Ratings for PDS Biotechnology

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for PDS Biotechnology (PDSB) stock?

A

The latest price target for PDS Biotechnology (NASDAQ:PDSB) was reported by HC Wainwright & Co. on September 17, 2024. The analyst firm set a price target for $21.00 expecting PDSB to rise to within 12 months (a possible 549.65% upside). 13 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for PDS Biotechnology (PDSB)?

A

The latest analyst rating for PDS Biotechnology (NASDAQ:PDSB) was provided by HC Wainwright & Co., and PDS Biotechnology reiterated their buy rating.

Q

When was the last upgrade for PDS Biotechnology (PDSB)?

A

There is no last upgrade for PDS Biotechnology

Q

When was the last downgrade for PDS Biotechnology (PDSB)?

A

There is no last downgrade for PDS Biotechnology.

Q

When is the next analyst rating going to be posted or updated for PDS Biotechnology (PDSB)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PDS Biotechnology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PDS Biotechnology was filed on September 17, 2024 so you should expect the next rating to be made available sometime around September 17, 2025.

Q

Is the Analyst Rating PDS Biotechnology (PDSB) correct?

A

While ratings are subjective and will change, the latest PDS Biotechnology (PDSB) rating was a reiterated with a price target of $21.00 to $21.00. The current price PDS Biotechnology (PDSB) is trading at is $3.23, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch